Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.
Byrd JC, Peterson BL, Rai KR, Hurd D, Hohl R, Perry MC, Gockerman J, Nattam S, Larson RA. Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901. Leuk Lymphoma. 2009 Oct; 50(10):1589-96.
-
Adult
-
Aged
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm
-
Antigens, CD
-
Antigens, Neoplasm
-
Anti-Infective Agents
-
Bone Marrow Diseases
-
Cohort Studies
-
Cytomegalovirus Infections
-
Feasibility Studies
-
Female
-
Glycoproteins
-
Humans
-
Hypotension
-
Infusions, Intravenous
-
Injections, Subcutaneous
-
Leukemia, Lymphocytic, Chronic, B-Cell
-
Male
-
Middle Aged
-
Neoplasm Proteins
-
Survival Analysis
-
Vidarabine